| Betamipron |
ベタミプロン |
3440-28-6 |
C10H11NO3 |
193.20
|
|
[日本上市数据][FDA GSRS]
|
| Betanidine Sulfate |
硫酸ベタニジン |
114-85-2 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Betaxolol Hydrochloride |
ベタキソロール塩酸塩 |
63659-19-8 |
C18H29NO3▪HCl |
343.89
|
|
[日本上市数据][FDA GSRS]
|
| Betazole Hydrochloride |
塩酸ベタゾール |
138-92-1 |
C5H9N3▪2HCl |
184.07
|
|
[日本上市数据][FDA GSRS]
|
| Bethanechol Chloride |
ベタネコール塩化物 |
590-63-6 |
C7H17ClN2O2 |
196.68
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) |
ベバシズマブ(遺伝子組換え) |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 1] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続1] |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 2] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続2] |
1438851-35-4 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 3] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続3] |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevacizumab (Genetical Recombination) [Bevacizumab Biosimilar 4] |
ベバシズマブ(遺伝子組換え)[ベバシズマブ後続4] |
216974-75-3 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bevantolol Hydrochloride |
ベバントロール塩酸塩 |
42864-78-8 |
C20H27NO4▪HCl |
381.89
|
|
[日本上市数据][FDA GSRS]
|
| Bevonium Methylsulfate |
メチル硫酸ベボニウム |
5205-82-3 |
C23H31NO7S |
465.57
|
|
[日本上市数据][FDA GSRS]
|
| Bexarotene |
ベキサロテン |
153559-49-0 |
C24H28O2 |
348.48
|
|
[日本上市数据][FDA GSRS]
|
| Bezafibrate |
ベザフィブラート |
41859-67-0 |
C19H20ClNO4 |
361.82
|
|
[日本上市数据][FDA GSRS]
|
| Bezlotoxumab (Genetical Recombination) |
ベズロトクスマブ(遺伝子組換え) |
1246264-45-8 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Biapenem |
ビアペネム |
120410-24-4 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bicalutamide |
ビカルタミド |
90357-06-5 |
C18H14F4N2O4S |
430.37
|
|
[日本上市数据][FDA GSRS]
|
| Bicozamycin |
ビコザマイシン |
38129-37-2 |
|
|
|
[日本上市数据][FDA GSRS]
|
| Bictegravir Sodium |
ビクテグラビルナトリウム |
1807988-02-8 |
C21H17F3N3NaO5 |
471.36
|
|
[日本上市数据][FDA GSRS]
|
| Bifemelane Hydrochloride |
塩酸ビフェメラン |
62232-46-6 |
C18H23NO▪HCl |
305.85
|
|
[日本上市数据][FDA GSRS]
|